• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Procter & Gamble Health Ltd Pharmaceuticals - Multinational

  • MNC Associate
  • BSE Code : 149.0
  • ISIN : INE199A01012
6,217.00 322 (5.45%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    5,895.50

  • Today’s High

    6,500.00

  • Open

    5,895.50

  • Perv Close

    5,895.50

  • 52W Low

    4,863.00

  • 52W High

    6,500.00

Key Indicators

  • P/E(TTM)

    39.57

  • Mar.Cap (₹Cr.)

    10,319.84

  • Div & Yield %

    0.00

  • Book Value(₹)

    323.48

  • Debt-Equity Ratio

    5.45

  • AGM Date

    01-Aug-2025

  • EPS

    156.67

  • P/E Ratio

    39.57

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    10,319.84

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.60

  • BV (₹)

    323.50

  • Sales( ₹ in Cr.)

    1,151.26

  • NP (in Cr.)

    215.69

  • NP Var(%)

    -6.0

  • Div%

    2600.0

  • CPS (₹)

    146.40

  • EPS (₹)

    129.90

  • Traded Value (₹ in Lakhs)

    10,291.12

  • 52 Week High

    6,500.00

  • 52 Week Low

    4,863.00

  • Price BSE

    6200.0

  • Price NSE

    6,217.00

  • Market Capital( in Cr.)

    10,291.12

  • P/C Ratio

    42.30

  • P/E Ratio

    47.70

  • Price Vs.BV

    129.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Jun 2023 Jun 2022 Jun 2021 Jun 2020 Jun 2018 Dec
INCOME :            
Sales Turnover 1,151.26 1,229.62 1,114.41 1,008.73 1,355.86 848.99
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,151.26 1,229.62 1,114.41 1,008.73 1,355.86 848.99
Other Income 15.63 18.39 13.19 18.10 68.89 767.93
Stock Adjustments -0.87 -2.85 4.75 -1.73 13.03 3.47
Total Income 1,166.02 1,245.16 1,132.35 1,025.10 1,437.78 1,620.39
EXPENDITURE :            
Raw Materials 329.69 358.99 344.55 310.39 444.47 272.83
Power and Fuel Cost 8.50 12.88 14.70 12.97 19.09 12.23
Employee Cost 215.16 206.17 167.56 153.66 182.93 131.27
Other Manufacturing Expenses 83.99 90.86 98.43 90.82 136.56 89.75
Selling and Administration Expenses 181.66 196.86 203.91 173.99 257.28 192.98
Miscellaneous Expenses 45.58 36.33 22.33 19.15 13.15 5.25
Employee Benefit Expenses 215.16 206.17 167.56 153.66 182.93 131.27
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 864.58 902.09 851.48 760.98 1,053.48 704.31
Operating Profit 301.44 343.07 280.87 264.12 384.30 916.08
Interest 0.72 0.77 0.42 0.80 0.00 0.00
Gross Profit 300.72 342.30 280.45 263.32 384.30 916.08
Depreciation 27.40 28.10 27.08 30.04 29.45 21.12
Profit Before Tax 273.32 314.20 253.37 233.28 354.85 894.96
Current Tax 80.94 89.79 60.81 63.60 94.78 50.22
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -8.60 -5.06 0.04 -7.12 5.99 6.02
Reported Net Profit 200.98 229.47 192.52 176.80 254.08 838.72
Extraordinary Items -14.71 0.51 -0.40 -0.31 -2.25 6.11
Adjusted Net Profit 215.69 228.96 192.92 177.11 256.33 832.61
Adjustment below Net Profit 0.67 -1.84 0.70 0.42 -159.42 -6.97
P & L Balance brought forward 370.91 237.07 327.70 532.26 1,167.97 361.12
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 414.99 93.79 283.85 381.78 730.37 24.90
P & L Balance carried down 157.57 370.91 237.07 327.70 532.26 1,167.97
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 2,600.00 950.00 525.00 1,300.00 2,300.00 4,400.00
Dividend Per Share(Rs) 260.00 95.00 52.50 130.00 230.00 440.00
Earnings Per Share-Unit Curr 121.07 138.23 115.98 106.51 102.04 505.25
Earnings Per Share(Adj)-Unit Curr 121.07 138.23 115.98 106.51 102.04 505.25
Book Value 324.24 452.34 371.38 423.92 545.99 927.78
Book Value(Adj)-Unit Curr 324.24 452.34 371.38 423.92 545.99 927.78

Shareholding Pattern

  • Promoter Group

    51.82%

  • Public Share Holding

    48.18%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 8,601,071 51.82 8,601,071 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 8,601,071 51.82 8,601,071 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 765 0.00 201 5
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,160,471 6.99 1,160,471 120
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 556,421 3.35 556,421 4
Mutual Funds / UTI 1,768,410 10.65 1,767,210 11
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 25,173 0.15 25,173 9
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,511,240 21.15 3,509,476 149
2] Non Institution
Bodies Corporate 274,797 1.66 271,832 542
Clearing Members 833 0.01 833 5
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 420,388 2.53 420,278 2,461
Foreign Non Institution Other 81 0.00 81 1
Hindu Undivided Families 92,839 0.56 92,839 1,184
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 236,358 1.42 236,358 3
Individuals holding nominal share capital up to Rs. 1 lakh 3,397,795 20.47 3,303,542 48,120
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,902 0.01 1,902 11
Others 62,078 0.37 62,078 1
Sub Total 4,487,071 27.03 4,389,743 52,328
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,599,382 100.00 16,500,290 52,478

Company Background

Procter & Gamble Health LtdPharmaceuticals - Multinational

  • Procter & Gamble Health Ltd
  • BSE Code : 149.0
  • ISIN : INE199A01012

  • Incorporation Year

    1967

  • Registered Office

    Godrej One 8th Floor
    Projshanagar Vikhroli (East), Mumbai,
    Maharashtra-400079

  • Telephone

    91-22-62109000

  • FAX

    91-22-62109999

  • Chairman

    S Madhavan

  • Managing Director

    Milind Thatte

  • Company Secretary

    Zeal Shah

  • Auditor

    Haribhakti & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Procter & Gamble Health Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Novartis India 967.25 398.23 356.27 23.23 16.64
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10